The present invention relates to a method of reducing total gas production and/or methane production in a ruminant animal.

The present invention relates to a method of reducing total gas production and/or methane production in a ruminant animal.

A seasoned laver includes laver; and hemp oil applied to the laver and a manufacturing method of seasoned laver includes: a steps of preparing dry raw laver; a steps of drying the dry raw laver; a steps of first roasting to manufacture roasted laver by adding a heat source to the dry raw laver and roasting; a steps of manufacturing seasoned laver by applying hemp oil to the roasted laver; and a steps of second roasting to apply a heat source to the seasoned laver.

A seasoned laver includes laver; and hemp oil applied to the laver and a manufacturing method of seasoned laver includes: a steps of preparing dry raw laver; a steps of drying the dry raw laver; a steps of first roasting to manufacture roasted laver by adding a heat source to the dry raw laver and roasting; a steps of manufacturing seasoned laver by applying hemp oil to the roasted laver; and a steps of second roasting to apply a heat source to the seasoned laver.

A seasoned laver includes laver; and hemp oil applied to the laver and a manufacturing method of seasoned laver includes: a steps of preparing dry raw laver; a steps of drying the dry raw laver; a steps of first roasting to manufacture roasted laver by adding a heat source to the dry raw laver and roasting; a steps of manufacturing seasoned laver by applying hemp oil to the roasted laver; and a steps of second roasting to apply a heat source to the seasoned laver.

The present disclosure describes a composition for nasal and/or oral administration comprising: magnesium and one or more components derived from a marine or marine-related plant in admixture in a saline base (e.g., including, but not limited to a saline base comprising seawater that is optionally filtered and/or sterilized and that is optionally diluted). Such compositions can, in some embodiments, decrease inflammation by affecting the release of certain pro-inflammatory neuropeptides.

The present disclosure describes a composition for nasal and/or oral administration comprising: magnesium and one or more components derived from a marine or marine-related plant in admixture in a saline base (e.g., including, but not limited to a saline base comprising seawater that is optionally filtered and/or sterilized and that is optionally diluted). Such compositions can, in some embodiments, decrease inflammation by affecting the release of certain pro-inflammatory neuropeptides.

A dietary supplement including monacolin K, phytosterols, policosanols, resveratrol, trimethylglycine and coenzyme Q10 is provided.

A dietary supplement including monacolin K, phytosterols, policosanols, resveratrol, trimethylglycine and coenzyme Q10 is provided.

A dietary supplement including monacolin K, phytosterols, policosanols, resveratrol, trimethylglycine and coenzyme Q10 is provided.